Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7729)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol 2017; 23(43): 7735-7745 [PMID: 29209114 DOI: 10.3748/wjg.v23.i43.7735] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i43/7735.htm |
| Number | Citing Articles |
| 1 |
Jinliang Zhang, Xihao Zhang, Han Mu, Ge Yu, Wenge Xing, Lu Wang, Ti Zhang. Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.729764
|
| 2 |
Duo Hong, Yi Zhou, Xiaoting Wan, Hongying Su, Haibo Shao. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08680-0
|
| 3 |
Chai Hong Rim, Sunmin Park, In-Soo Shin, Won Sup Yoon. Is the Concurrent Use of Sorafenib and External Radiotherapy Feasible for Advanced Hepatocellular Carcinoma? A Meta-Analysis. Cancers 2021; 13(12): 2912 doi: 10.3390/cancers13122912
|
| 4 |
Abdul Rehman Khan, Xuyong Wei, Xiao Xu. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides. Journal of Hepatocellular Carcinoma 2021; : 1089 doi: 10.2147/JHC.S318070
|
| 5 |
Yue Zhang, Yi-Fan Wu, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Liang He, Tao Wang, Fu-Quan Liu. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World Journal of Gastrointestinal Oncology 2019; 11(4): 310-321 doi: 10.4251/wjgo.v11.i4.310
|
| 6 |
Kaihao Xu, Chuan Tian, Yiming Liu, Kunpeng Wu, Dechao Jiao, Xinwei Han. Is iodine-125 seed strand brachytherapy suitable for ureteral carcinoma?. Urologic Oncology: Seminars and Original Investigations 2022; 40(12): 537.e11 doi: 10.1016/j.urolonc.2022.08.009
|
| 7 |
Xue-Fen Lei, Yang Ke, Tian-Hao Bao, Hao-Ran Tang, Xue-Song Wu, Zhi-Tian Shi, Jie Lin, Zhi-Xian Zhang, Hou Gu, Lin Wang. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World Journal of Clinical Cases 2018; 6(5): 74-83 doi: 10.12998/wjcc.v6.i5.74
|
| 8 |
Fangzhou Luo, Mengxia Li, Jun Ding, Shusen Zheng. The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.635731
|
| 9 |
Wei Huang, Ju Gong, Qingbing Wang, Ziyin Wang, Qin Liu, Jingjing Liu, Junwei Gu, Xiaoyi Ding, Zhiyuan Wu. Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.973357
|
| 10 |
Zi-Han Zhang, Wen Zhang, Qing-Xin Liu, Jing-Qin Ma, Min-Jie Yang, Ling-Xiao Liu, Jian-Jun Luo, Zhi-Ping Yan. Embolization of the Transhepatic Tract after Percutaneous Portal Vein Interventions: Single-Centre Retrospective Study Comparing n-butyl Cyanoacrylate Versus Coils. CardioVascular and Interventional Radiology 2021; 44(11): 1728 doi: 10.1007/s00270-021-02883-5
|
| 11 |
Wei-Fan Sui, Jian-Yun Li, Jian-Hua Fu. Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis. World Journal of Clinical Oncology 2024; 15(3): 447-455 doi: 10.5306/wjco.v15.i3.447
|
| 12 |
Lei Zhang, Bo Hu, Wei Li, Peng Huang, Shen Zhang, Bin-Yan Zhong, Cai-Fang Ni. 125I Irradiation Stent for Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis: A Systematic Review. CardioVascular and Interventional Radiology 2020; 43(2): 196 doi: 10.1007/s00270-019-02346-y
|
| 13 |
Bei Wu, Guowen Yin, Xu He, Guoping Chen, Boxiang Zhao, Jinhua Song, Jianping Gu. Endovascular Treatment of Cancer-Associated Venous Obstruction: Comparison of Efficacy Between Stent Alone and Stent Combined With Linear Radioactive Seeds Strand. Vascular and Endovascular Surgery 2020; 54(7): 565 doi: 10.1177/1538574420939747
|
| 14 |
Zi-Han Zhang, Si-Nan Hou, Jia-Ze Yu, Wen Zhang, Jing-Qin Ma, Min-Jie Yang, Qing-Xin Liu, Ling-Xiao Liu, Jian-Jun Luo, Xu-Dong Qu, Zhi-Ping Yan. Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1086095
|
| 15 |
|
| 16 |
Nan Du, Jingqin Ma, Zihan Zhang, Yongjie Zhou, Minjie Yang, Wen Zhang, Jianjun Luo, Zhiping Yan. Development of a Novel Endovascular Brachytherapy Stent: A Proof-of-concept Study. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00128
|
| 17 |
Jian Lu, Jin-He Guo, Jian-Song Ji, Yu-Liang Li, Wei-Fu Lv, Hai-Dong Zhu, Jun-Hui Sun, Wei-Xin Ren, Fu-Jun Zhang, Wei-Dong Wang, Hai-Bo Shao, Guang-Shao Cao, Hai-Liang Li, Kun Gao, Po Yang, Guo-Wen Yin, Guang-Yu Zhu, Fa-Zong Wu, Wu-Jie Wang, Dong Lu, Sheng-Qun Chen, Jie Min, Yang Zhao, Rui Li, Li-Gong Lu, Wan Yee Lau, Gao-Jun Teng. Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial. International Journal of Surgery 2023; 109(5): 1188 doi: 10.1097/JS9.0000000000000295
|